Clinical research of esophageal cancer patients treated by combined composite Shenqi 11 flavor granules and 3 dimensional conformal radiotherapy

SHEN Ze-tian,WU Xin-hu,LI Bing,WANG Lei,ZHU Xi-xu
DOI: https://doi.org/10.3969/j.issn.1672-4992.2010.11.22
2010-01-01
Journal of Modern Oncology
Abstract:Objective:To analyze the efficacy and the toxicity of 3 dimensional conformal radiotherapy combined with composite Shenqi 11 flavor granules in treatment of esophageal carcinoma patients.Methods:A total of 136 cases of esophageal cancer were treated by radiotherapy.All patients were treated with the continuative fractionated radiotherapy.The total dose was 64-72Gy/5-7w,1.8-2.0Gy/d of esophageal carcinoma patients.Two groups were given respectively delivered with the same radioactive dosages and methods.But the treatment group was treated by radiotherapy and Shenqi 11 flavor granules.Results:The total effective rate(CR+PR)of X-ray manifestation after radiotherapy for patients in treatment group was superior than the patients in radiotherapy alone group(91.2% vs 76.5%;P<0.05).The complete remission rate was also much higher in treatment group than radiotherapy alone group(52.9% vs 44.1%).Radiation-esophagitis,radiation pneumonitis was much higher in radiotherapy alone group(P<0.01,P<0.05).Also the overall toxicity rate was much higher in radiotherapy alone group than treatment group(29.4% vs 14.7%,P<0.05).Conclusion:Composite Shenqi 11 flavor granules can improve Short-term curative effect of 3 dimensional conformal radiotherapy of esophageal cancer and significantly decreased side effect of radiotherapy.
What problem does this paper attempt to address?